Rechercher dans ce blog

Friday, September 30, 2022

Can Smartphones Help Predict Suicide? - The New York Times

A unique research project is tracking hundreds of people at risk for suicide, using data from smartphones and wearable biosensors to identify periods of high danger — and intervene.

CAMBRIDGE, Mass. — In March, Katelin Cruz left her latest psychiatric hospitalization with a familiar mix of feelings. She was, on the one hand, relieved to leave the ward, where aides took away her shoelaces and sometimes followed her into the shower to ensure that she would not harm herself.

But her life on the outside was as unsettled as ever, she said in an interview, with a stack of unpaid bills and no permanent home. It was easy to slide back into suicidal thoughts. For fragile patients, the weeks after discharge from a psychiatric facility are a notoriously difficult period, with a suicide rate around 15 times the national rate, according to one study.

This time, however, Ms. Cruz, 29, left the hospital as part of a vast research project which attempts to use advances in artificial intelligence to do something that has eluded psychiatrists for centuries: to predict who is likely to attempt suicide and when that person is likely to attempt it, and then, to intervene.

On her wrist, she wore a Fitbit programmed to track her sleep and physical activity. On her smartphone, an app was collecting data about her moods, her movement and her social interactions. Each device was providing a continuous stream of information to a team of researchers on the 12th floor of the William James Building, which houses Harvard’s psychology department.

In the field of mental health, few new areas generate as much excitement as machine learning, which uses computer algorithms to better predict human behavior. There is, at the same time, exploding interest in biosensors that can track a person’s mood in real time, factoring in music choices, social media posts, facial expression and vocal expression.

Matthew K. Nock, a Harvard psychologist who is one of the nation’s top suicide researchers, hopes to knit these technologies together into a kind of early-warning system that could be used when an at-risk patient is released from the hospital.

He offers this example of how it could work: The sensor reports that a patient’s sleep is disturbed, she reports a low mood on questionnaires and GPS shows she is not leaving the house. But an accelerometer on her phone shows that she is moving around a lot, suggesting agitation. The algorithm flags the patient. A ping sounds on a dashboard. And, at just the right time, a clinician reaches out with a phone call or a message.

There are plenty of reasons to doubt that an algorithm can ever achieve this level of accuracy. Suicide is such a rare event, even among those at highest risk, that any effort to predict it is bound to result in false positives, forcing interventions on people who may not need them. False negatives could thrust legal responsibility onto clinicians.

Algorithms require granular, long-term data from a large number of people, and it’s nearly impossible to observe large numbers of people who die by suicide. Finally, the data needed for this kind of monitoring raises red flags about invading the privacy of some of society’s most vulnerable people.

Dr. Nock is familiar with all these arguments but has persisted, in part out of sheer frustration. “With all due respect to people who’ve been doing this work for decades, for a century, we haven’t learned a great deal about how to identify people at risk and how to intervene,” he said. “The suicide rate now is the same it was literally 100 years ago. So just if we’re being honest, we’re not getting better.”

Kayana Szymczak for The New York Times

For psychiatrists, few tasks are more nerve-racking than caring for patients they know to be at risk for suicide while they are at home and unsupervised.

Dr. Karen L. Swartz, a professor of psychiatry at Johns Hopkins University, calls it “the gray zone.” She was fresh out of training when she first wrestled with this problem, caring for a prickly, intelligent woman who admitted she had suicidal thoughts, and even alluded to a plan, but dreaded the thought of being hospitalized.

Dr. Swartz turned to the woman’s husband for advice. If you force her into the hospital, he said, she will fire you.

So Dr. Swartz decided to take the risk, allowing the woman to remain at home, tweaking her medications and waiting. She spent the next weeks on tenterhooks, and, slowly, the patient improved. “It was one of those things where I just genuinely hoped I was right,” she said. It never gets easier, said Dr. Swartz, who now trains young psychiatrists: With experience, it only becomes clearer that suicidal thoughts can come and go without warning.

“We are asked to predict something that is highly unpredictable,” she said.

Increasingly, health care systems are turning to machine learning to make this call. Algorithms based on vast data sets — drawn from electronic medical records as well as scores of other factors — are used to assign patients a risk score, so that individuals at exceptionally high risk can be provided with extra attention.

Algorithms have proven more accurate than traditional methods, which, according to a 2017 review of published research, had not improved in 50 years and were only slightly better than chance at predicting an outcome. These methods are already used in some clinical settings. Since 2017, the Department of Veterans Affairs has used an algorithm to flag the 0.1 percent of veterans at the highest risk for suicide, a few thousand patients in a population of six million.

This approach has yielded some success. A study published last year in JAMA Network Open found that veterans enrolled in REACH VET, a program for at-risk patients, were 5 percent less likely to have a documented suicide attempt, and less likely to be admitted to a psychiatric facility or visit the emergency room. But the study found no significant change in the rate of suicide.

The expectations that have built up around this research are so high that experts take pains to temper them. Michael Schoenbaum, a senior adviser at the National Institute of Mental Health, compared it to the excitement, 25 years ago, around the search for biological markers for mental illnesses — a case in which, he pointed out, “the optimists were wrong.”

“We are waiting to see when and where and maybe even whether signals like that are valid and reliable,” he said. “The evidence so far, it’s exciting in the sense that any signal is promising. This is something that we couldn’t do before at all.” But, he warned, “we are looking for something we haven’t found yet.”

And some of Dr. Nock’s colleagues say they doubt algorithmic predictions will ever be precise enough to intervene in the narrow window that precedes a suicide attempt.

“It’s certainly not an easily solvable problem,” said Nick Allen, the director of the Center for Digital Mental Health at the University of Oregon, who helped develop EARS, an app that tracks mood based on factors like music choice, facial expression and the use of language.

“It’s probably, in some senses, not a solvable problem, for the same reason that we have school shootings and the same reason that we can’t predict a lot of this kind of stuff,” Dr. Allen said. “You know, the math is just really daunting.”

Kayana Szymczak for The New York Times

On an August afternoon in the William James building, a lanky data scientist named Adam Bear sat in front of a monitor in Dr. Nock’s lab, wearing flip-flops and baggy shorts, staring at the zigzagging graphs of a subject’s stress levels over the course of a week.

When moods are mapped as data, patterns emerge, and it’s Mr. Bear’s job to look for them. He spent his summer poring through the days and hours of 571 subjects who, after seeking medical care for suicidal thoughts, agreed to be tracked continuously for six months. While they were being tracked, two died by suicide and between 50 and 100 made attempts.

It is, Dr. Nock believes, the largest reservoir of information ever collected about the daily lives of people struggling with suicidal thoughts.

The team is most interested in the days preceding suicide attempts, which would allow time for intervention. Already, some signs have emerged: Although suicidal urges often do not change in the period before an attempt, the ability to resist those urges does seem to diminish. Something simple — sleep deprivation — seems to contribute to that.

Dr. Nock has been looking for ways to study these patients since 1994, when he had an experience that shocked him profoundly. During an undergraduate internship in the United Kingdom, he was assigned to a locked unit for violent and self-injurious patients. There, he saw things he had never encountered: Patients had cuts up and down their arms. One of them pulled out his own eyeball. A young man he befriended, who seemed to be improving, was later found in the Thames.

Another shock came when he began to pepper the clinicians with questions about treating these patients and realized how little they knew: He recalls being told, “We give them some medicine, we talk to them and we hope they get better.”

One reason, he concluded, was that it had never been possible to study a large number of people with suicidal ideation in the same way that we are able to observe patients with heart disease or tuberculosis. “Psychology hasn’t advanced as much as other sciences because we’ve been largely doing it wrong,” he said. “We haven’t gone out and found some behavior that is important in nature, and gone out and observed it.”

But with the advent of phone-based apps and wearable sensors, he added, “we have data from so many different channels, and we have, increasingly, the ability to analyze those data, and observe people as they’re out living their lives.” One dilemma in designing the study was what to do when participants expressed a strong desire to hurt themselves. Dr. Nock decided they should intervene.

“There’s a downside to this because you get fewer attempts and fewer suicides, because, scientifically, we’re now decreasing our likelihood of finding a signal,” he said. But, he added, “I keep coming back to the issue of, what if it was my child?”

Interventions have become a routine part of life in the lab. If, in a routine questionnaire, a subject reports a strong desire to harm themselves, and it is between the hours of 9 a.m. and 9 p.m., they receive a call within 15 minutes from one of the researchers, who asks whether they have made an attempt.

“We’re kind of this faceless person, so there’s less discomfort,” said Narise Ramlal, a research assistant in the lab. But Dr. Nock wonders — and hopes to test — whether digital interventions may prove to be more effective.

“Many people don’t want a human to contact them when they’re a high risk,” he said. “Not to say that we’re going to replace humans with machines, but they can probably be a lot more efficient than we are now.”

Kayana Szymczak for The New York Times

It was around 9 p.m., a few weeks into the six-month study, when the question popped up on Ms. Cruz’s phone: “Right now how strong is your desire to kill yourself?”

Without stopping to think, she dragged her finger all the way to the end of the bar: 10. A few seconds later, she was asked to choose between two statements: “I am definitely not going to kill myself today” and “I am definitely going kill myself today.” She scrolled to the second.

Fifteen minutes later, her phone rang. It was a member of the research team calling her. The woman called 911 and kept Ms. Cruz on the line until the police knocked on her door, and she passed out. Later, when she regained consciousness, a medical team was giving her a sternum rub, a painful procedure used to revive people after overdoses.

Ms. Cruz has a pale, seraphic face and a fringe of dark curls. She had been studying for a nursing degree when a cascade of mental health crises sent her life swerving in a different direction. She maintains an A-student’s nerdy interest in science, joking that the rib cage on her T-shirt is “totally anatomically correct.”

Right away, she had been intrigued by the trial, and she responded dutifully six times a day, when the apps on her phone surveyed her about her suicidal thoughts. The pings were intrusive, but also comforting. “It felt like I wasn’t being ignored,” she said. “To have somebody know how I feel, that takes some of the weight off.”

On the night of her attempt, she was alone in a hotel room in Concord. She didn’t have enough money for another night there, and her possessions were mounded in trash bags on the floor. She was tired, she said, “of feeling like I had nobody and nothing.” Looking back, Ms. Cruz said she thought the technology — its anonymity and lack of judgment — made it easier to ask for help.

“I think it’s almost easier to tell the truth to a computer,” she said.

But many in the field are wary of the idea that technology can ever substitute for a clinician’s care. One reason is that patients in a crisis become skilled at deception, said Justin Melnick, 24, a doctoral student who survived a suicide attempt in 2019 and is now an advocate for people with mental illness.

He recalled cutting short telephone conversations with his mother, the person best able to pull him off “the precipice,” and then switching his phone off. “And it was like, OK, that door has been closed,” he said. He described these evasions as “an act of defiance.” Why, he asked, would a person in that frame of mind agree to wear a sensor?

In the end, he said, what helped him turn the corner was people — a support group, which met weekly in a circle of chairs for sessions of dialectical behavioral therapy, and a network of friends, family and clinicians who know him well enough to recognize his behavior. When that happens, he said, “we can generally ride that wave together.”

Ms. Cruz does not have a network like that. Last month, as temperatures in Massachusetts were dipping into the 40s, she was living in a tent with her boyfriend, huddling together under a blanket for warmth. In the morning, they waited until McDonald’s opened so they could dry out their sweatshirts and shoes and charge their devices.

She was faithful about taking her medications — five of them — but was scrambling to find a new therapist: The only one in her area who accepts Medicaid has an eight-month waiting list.

Last week, as the six-month clinical trial came to an end, she filled out her final questionnaire with a twinge of sorrow. She would miss the $1 she received for each response. And she would miss the sense that someone was watching her, even if it was someone faceless, at a distance, through a device.

“Honestly, it makes me feel a little bit safer to know that somebody cares enough to read that data every day, you know?” she said. “I’ll be kind of sad when it’s over.”

If you are having thoughts of suicide, text the National Suicide Prevention Lifeline at 988 or go to SpeakingOfSuicide.com/resources for a list of additional resources.

Adblock test (Why?)



Health - Latest - Google News
September 30, 2022 at 11:27PM
https://ift.tt/CzZ16Ta

Can Smartphones Help Predict Suicide? - The New York Times
Health - Latest - Google News
https://ift.tt/8zgNcbp

Second COVID booster effective at preventing hospitalizations and deaths in nursing home residents: study - The Hill

A new study published this week found that the second COVID-19 booster that was made available to U.S. adults older than 50 this year was highly effective at protecting nursing home residents from hospitalizations and deaths, though its ability to prevent infections was not as potent.

The analysis, published in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report, compared nursing home residents who received a second original mRNA booster dose to those who did not get the additional shot.

According to the study, the second shot was 90 percent effective at preventing coronavirus-related deaths and 74 percent effective at preventing severe cases that led to either hospitalizations or deaths.

The shot was about 26 percent effective at preventing infection, however. This study looked at cases between March 29 and July 25. It was within this period that the BA.5 omicron subvariant grew to become dominant in the U.S.

By the end of July, BA.5 was accounting for four out of five coronavirus cases, and experts had noted its ability to evade protection from immunization and prior infection.

The 9,527 nursing home residents who were included in the study had received their booster within 60 days when they were followed up on by researchers. In order to be eligible, participants had to have stayed in a nursing home for more than 100 days, spent less than 10 outside of the facility and received three prior vaccine doses, with the last dose received more than 120 days beforehand.

Nearly 200 nursing homes from 19 states were included in the study.

Nursing homes have been disproportionately impacted by the coronavirus throughout the pandemic. Roughly three out of four COVID-19 deaths have been among those over the age of 65. When the delta variant spread throughout the U.S. last year, coronavirus deaths rose at a faster rate in nursing homes than in the rest of the country.

“These findings suggest that among nursing home residents, second mRNA COVID-19 vaccine booster doses provided additional protection over first booster doses against severe COVID-19 outcomes during a time of emerging Omicron variants,” researchers wrote.

“Facilities should continue to ensure that nursing home residents remain up to date with COVID-19 vaccination, including bivalent vaccine booster doses, to prevent severe COVID-19 outcomes.”

White House COVID-19 response coordinator Ashish Jha hailed the study’s findings.

“This is why we’re so focused on ensuring folks, particularly the high risk, get the latest vaccine,” Jha tweeted.

If they have not been recently vaccinated once more or infected with the virus, many of the participants in this study would now be eligible to receive the bivalent omicron-specific COVID-19 booster. The updated shot was authorized at the end of August.

The White House has strongly encouraged eligible individuals to get the bivalent booster, hoping to avoid another surge in coronavirus cases in the fall and winter. The dose has been followed by some uncertainty, as it was approved before a full human study was completed, with both Pfizer and Moderna submitting animal data, as is done for annual flu shots.

Pfizer and Moderna have recently submitted applications seeking authorization from the Food and Drug Administration to administer their shots in younger populations. Pfizer’s bivalent booster is authorized for children as young as 12, while Moderna’s is currently only authorized for adults.

Adblock test (Why?)



Health - Latest - Google News
September 30, 2022 at 04:40AM
https://ift.tt/o8Wx6Jz

Second COVID booster effective at preventing hospitalizations and deaths in nursing home residents: study - The Hill
Health - Latest - Google News
https://ift.tt/8zgNcbp

Wednesday, September 28, 2022

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes | NEJM - nejm.org

The authors’ full names and academic degrees are as follows: Steven J. Russell, M.D., Ph.D., Roy W. Beck, M.D., Ph.D., Edward R. Damiano, Ph.D., Firas H. El-Khatib, Ph.D., Katrina J. Ruedy, M.S.P.H., Courtney A. Balliro, R.N., C.D.C.E.S., C.R.N.-B.C., Zoey Li, M.S., Peter Calhoun, Ph.D., R. Paul Wadwa, M.D., Bruce Buckingham, M.D., Keren Zhou, M.D., Mark Daniels, M.D., Philip Raskin, M.D., Perrin C. White, M.D., Jane Lynch, M.D., Jeremy Pettus, M.D., Irl B. Hirsch, M.D., Robin Goland, M.D., John B. Buse, M.D., Ph.D., Davida Kruger, M.S.N., A.P.N.-B.C., B.C.-A.D.M., Nelly Mauras, M.D., Andrew Muir, M.D., Janet B. McGill, M.D., Fran Cogen, M.D., C.D.C.E.S., Jill Weissberg-Benchell, Ph.D., C.D.C.E.S., Jordan S. Sherwood, M.D., Luz E. Castellanos, M.D., Mallory A. Hillard, M.S.N., N.P., A.G.P.C.N.P.-B.C., Marwa Tuffaha, M.D., Melissa S. Putman, M.D., Mollie Y. Sands, M.D., Gregory Forlenza, M.D., Robert Slover, M.D., Laurel H. Messer, Ph.D., R.N., C.D.C.E.S., Erin Cobry, M.D., Viral N. Shah, M.D., Sarit Polsky, M.D., M.P.H., Rayhan Lal, M.D., Laya Ekhlaspour, M.D., Michael S. Hughes, M.D., Marina Basina, M.D., Betul Hatipoglu, M.D., Leann Olansky, M.D., Amrit Bhangoo, M.D., Nikta Forghani, M.D., Himala Kashmiri, M.D., Francoise Sutton, P.N.P., M.S.N., Abha Choudhary, M.D., Jimmy Penn, M.S.N., A.P.R.N., F.N.P.-C., C.D.C.E.S., Rabab Jafri, M.D., Maria Rayas, M.D., Elia Escaname, M.D., Catherine Kerr, M.D., Ruby Favela-Prezas, M.S.N., A.P.R.N., F.N.P.-B.C., Schafer Boeder, M.D., Subbulaxmi Trikudanathan, M.D., Kristen M. Williams, M.D., Natasha Leibel, M.D., M. Sue Kirkman, M.D., Kate Bergamo, F.N.P.-C., Klara R. Klein, M.D., Ph.D., Jean M. Dostou, M.D., Sriram Machineni, M.D., Laura A. Young, M.D., Ph.D., Jamie C. Diner, M.S.N., F.N.P.-C., R.N., C.D.E., Arti Bhan, M.D., J. Kimberly Jones, A.P.N.-B.C., B.C.-A.D.M., Matthew Benson, M.D., Keisha Bird, D.N.P., A.P.R.N., B.C.-A.D.M., Kimberly Englert, R.N., C.C.R.C., Joe Permuy, M.S.N., A.P.R.N., Kristina Cossen, M.D., Eric Felner, M.D., Maamoun Salam, M.D., Julie M. Silverstein, M.D., Samantha Adamson, M.D., Ph.D., Andrea Cedeno, M.D., Seema Meighan, C.P.N.P., and Andrew Dauber, M.D.

The authors’ affiliations are as follows: the Diabetes Research Center, Massachusetts General Hospital (S.J.R., C.A.B., J.S.S., L.E.C., M.A.H., M.T., M.S.P., M.Y.S.), and Boston University (E.R.D.), Boston, and Beta Bionics, Concord (E.R.D., F.H.E.-K.) — all in Massachusetts; the Jaeb Center for Health Research, Tampa (R.W.B., K.J.R., Z.L., P.C.), and Nemours Children’s Health Jacksonville, Jacksonville (N.M., M. Benson, K. Bird, K.E., J. Permuy) — both in Florida; the Barbara Davis Center for Diabetes, University of Colorado, Aurora (R.P.W., G.F., R.S., L.H.M., E.C., V.N.S., S.P.); Stanford University School of Medicine, Palo Alto (B.B., R.L., L.E., M.S.H., M. Basina), Children’s Hospital of Orange County, Orange (M.D., A. Bhangoo, N.F., H.K., F.S.), and the University of California, San Diego, La Jolla (J. Pettus, S.B.) — all in California; Cleveland Clinic, Cleveland (K.Z., B.H., L.O.); University of Texas Southwestern Medical Center, Dallas (P.R., P.C.W., A. Choudhary, J. Penn), and University of Texas Health Science Center, San Antonio (J.L., R.J., M.R., E.E., C.K., R.F.-P.); the University of Washington, Seattle (I.B.H., S.T.); the Naomi Berrie Diabetes Center, Columbia University, New York (R.G., K.M.W., N.L.); the University of North Carolina, Chapel Hill (J.B.B., M.S.K., K. Bergamo, K.R.K., J.M.D., S. Machineni, L.A.Y., J.C.D.); the Henry Ford Health System, Detroit (D.K., A. Bhan, J.K.J.); Emory University, Atlanta (A.M., K.C., E.F.); Washington University in St. Louis, St. Louis (J.B.M., M.S., J.M.S., S.A., A. Cedeno); Children’s National Hospital, Washington, DC (F.C., S. Meighan, A.D.); and the Pritzker Department of Psychiatry and Behavioral Health, Ann and Robert Lurie Children’s Hospital, Chicago (J.W.-B.).

Adblock test (Why?)



Health - Latest - Google News
September 29, 2022 at 04:08AM
https://ift.tt/Cv8r29S

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes | NEJM - nejm.org
Health - Latest - Google News
https://ift.tt/tzlDsJS

First on CNN: Unvaccinated individuals 14 times more likely to get monkeypox than vaccinated, new US data shows - CNN

CNN  — 

Eligible individuals who did not receive the monkeypox vaccine were around 14 times likelier to become infected with the virus than those who were vaccinated, according to federal government data described to CNN by multiple US health officials.

That figure reflects the first wave of authoritative data collected by the Biden administration on the efficacy of the monkeypox vaccine that is currently being administered across the United States. The data marks an important milestone in the administration’s fight against monkeypox, particularly given the unprecedented nature of this year’s outbreak. Details of these early findings, said to be based on data collected from 32 states, could be unveiled publicly as early as Wednesday, when the White House monkeypox response team is expected to hold its next press briefing.

Multiple health officials said that the vaccines data has the administration feeling increasingly optimistic about the efficacy of the two-dose Jynneos monkeypox vaccine – and the possibility of ultimately eliminating the current outbreak in the US altogether.

“We are cautiously optimistic about the study and think if we continue to get vaccines out to those that are at highest risk for disease, and if we continue to promote the behavioral changes that we know work, that the combination of those two will allow us to continue to see decreases in cases and hopefully eliminate the current monkeypox outbreak in the United States,” one senior health official told CNN.

The official cautioned that there are some important caveats to the findings. For example, the latest study can’t say how much changes in human behavior might be a factor for the vaccinated individuals, they said.

“What it doesn’t let us do is fully disentangle pieces of this that may be behavioral change pieces that may be related to sexual networks or to who people are coming into contact with,” the official said. “We know that at the start of the monkeypox outbreak, a lot of gay and bisexual men changed their behaviors.”

There are also outstanding questions about durability of the vaccine and how long the protection would last. US health officials have seen protection from monkeypox for those vaccinated with Jynneos as early as two weeks after the first dose, but are continuing to push for anyone eligible to get both doses of the vaccine regimen for maximum protection.

“We know this is a two-dose vaccine and we’re continuing to encourage people to get the second dose because all of the prior studies have shown that when you get that second dose, you have a more profound immune response,” the official said.

These findings coincide with a sense of “cautious optimism” recently expressed by top US health officials about the general trajectory of the outbreak, as the country has seen a decline in new monkeypox cases. More than 25,000 US monkeypox cases have been identified during the outbreak.

“Over the last several weeks, we’ve been pleased to see a decline in the growth of new cases here and abroad, though there are areas of the US where the rate of rise in new cases is still increasing,” US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said earlier this month. “We approach this news with cautious optimism.”

Adblock test (Why?)



Health - Latest - Google News
September 28, 2022 at 07:50PM
https://ift.tt/MKtCnFJ

First on CNN: Unvaccinated individuals 14 times more likely to get monkeypox than vaccinated, new US data shows - CNN
Health - Latest - Google News
https://ift.tt/H567m3l

Study Links Coffee—Even Decaf and Instant—to Longer Life - Gizmodo

Image for article titled Study Links Coffee—Even Decaf and Instant—to Longer Life
Photo: Shutterstock (Shutterstock)

Coffee: still tasty, and still apparently good for us. A study out this week suggests that light to moderate consumption of decaffeinated, ground, and instant coffee can be linked to a lower risk of dying early and developing cardiovascular disease. As is often the case, though, these findings alone can’t confirm a direct cause-and-effect relationship between coffee and our health.

Scientists in Australia analyzed data from the UK Biobank, a long-running research project that’s tracking the health of the country’s residents. At the start of the project, volunteers detailed their dieting habits, including their usual amount and type of coffee-drinking. The researchers focused on nearly 450,000 volunteers with no diagnosed cardiovascular disease at the start of the study over the age of 40 and then tracked their health and mortality over a 12-year follow-up period.

Compared to non-coffee drinkers, coffee drinkers in general were less likely to develop cardiovascular disease and to die from any cause at all during that time. But there were some subtle differences in the associated benefits found between the amount and type of coffee drinking. People who drank two to three cups of decaffeinated, ground, or instant coffee a day had the greatest reductions in mortality. Those who drank one to five cups a day of ground and instant coffee were the least likely to develop arrhythmia, or an irregular heartbeat, while no associated benefit was seen for people who drank decaf. The findings were published Monday in the European Journal of Preventive Cardiology.

Many studies have suggested that coffee consumption is overall good for people, including a study that similarly analyzed UK Biobank data published this May. But the authors say theirs is one of the few to look specifically at the type of coffee that people are drinking. Their results, they argue, indicate that coffee’s likely benefits don’t just come from the consumption of caffeine, but from other ingredients and possibly how it’s prepared. Some evidence has suggested, for example, that compounds called diterpenes can raise the risk of LDL cholesterol (the “bad” kind), and these oily compounds are more common in brewed ground coffee that’s left unfiltered.

“Caffeine is the most well-known constituent in coffee, but the beverage contains more than 100 biologically active components. It is likely that the non-caffeinated compounds were responsible for the positive relationships observed between coffee drinking, cardiovascular disease and survival,” said study author Peter Kistler, a researcher at the Baker Heart and Diabetes Research Institute in Melbourne, in a statement from the European Society of Cardiology, the journal’s publishers.

By this point, given all the research that’s been conducted, it would be pretty shocking if coffee didn’t turn out to be mostly beneficial for our health. But the trouble is that it’s hard to say much further beyond that. Most coffee studies rely on analyzing observational population-level data, which can only really show a correlation between any two factors, not demonstrate a direct cause-and-effect. And while researchers try to account for other factors that might explain why a particular correlation exists, they don’t always succeed. People who regularly drink coffee, for instance, might be different from non-drinkers in important ways that can’t be seen from the data.

Probably the best way to settle this debate would be to conduct randomized studies of coffee drinking, though it would cost a pretty penny to do so. In the meantime, so long as you’re not drowning yourself in coffee every day, you’ll likely be fine either way. And some people with anxiety conditions may actually want to avoid caffeine, since it could worsen their symptoms.

Adblock test (Why?)



Health - Latest - Google News
September 28, 2022 at 03:33AM
https://ift.tt/GADnHSj

Study Links Coffee—Even Decaf and Instant—to Longer Life - Gizmodo
Health - Latest - Google News
https://ift.tt/H567m3l

Tuesday, September 27, 2022

CDC no longer recommends universal masking in health facilities - WOODTV.com

[unable to retrieve full-text content]

CDC no longer recommends universal masking in health facilities  WOODTV.comView Full Coverage on Google News

Health - Latest - Google News
September 27, 2022 at 06:26PM
https://ift.tt/oCbwLQh

CDC no longer recommends universal masking in health facilities - WOODTV.com
Health - Latest - Google News
https://ift.tt/H567m3l

CDC Issues Overhaul to Mask Mandate in Hospitals and Nursing Homes - The Epoch Times

The U.S. Centers for Disease Control and Prevention (CDC) issued a change to its guidance late last week and will no longer require nursing homes and hospitals to require masking in some areas.

In a revision on Sept. 23, the CDC said that nursing home facilities and hospitals in a number of areas without “high” community transmission can choose not to require” all doctors, patients, and visitors to wear masks. It’s one of many changes to the CDC’s COVID-19 guidance since August when the agency’s leadership announced an overhaul of how it responds to pandemics.

“Updates were made to reflect the high levels of vaccine-and infection-induced immunity and the availability of effective treatments and prevention tools,” the CDC said.

Recent CDC data used to inform health care facilities shows that about 73 percent of counties in the United States are seeing “high” community transmission of COVID-19. About 26.9 percent, meanwhile, are meeting low, moderate, or substantial transmission, according to the data, indicating that facilities in those areas don’t have to mandate masks.

“Community transmission is the metric currently recommended to guide select practices in healthcare settings to allow for earlier intervention, before there is strain on the healthcare system and to better protect the individuals seeking care in these settings,” the CDC stated in its updated guidance.

Early on in the pandemic, the CDC recommended everyone wear masks or respirators in health care facilities or nursing homes. Exceptions were later included visitors who choose not to wear masks if they had updated COVID-19 vaccines and were alone with the person they were visiting.

“Vaccination status is no longer used to inform source control, screening testing, or post-exposure recommendations,” the guidance now says.

Holly Harmon, a senior vice president for the American Health Care Association as well as the National Center for Assisted Living, praised the recent CDC guidance change.

“While our commitment to infection prevention and control continues, adapting COVID protocols means recognizing the current stage of this pandemic as well as the importance of quality of life for our nation’s seniors,” Harmon said, reported CBS News.

Overhaul

In mid-August, new guidelines published by the federal agency no longer recommend staying at least six feet away from other people to reduce exposure.

And the agency stated at the time that it’s no longer recommending unvaccinated people to quarantine after exposure. Unvaccinated people who have been in close contact with an infected person aren’t advised to go through a five-day quarantine period if they haven’t tested positive or shown symptoms.

“CDC’s COVID-19 prevention recommendations no longer differentiate based on a person’s vaccination status because breakthrough infections occur, though they are generally mild, and persons who have had COVID-19 but are not vaccinated have some degree of protection against severe illness from their previous infection,” the CDC said at the time amid additional announced changes.

But notably, the CDC is still requiring non-citizen international travelers to show proof of COVID-19 vaccination before entering the United States, according to its website. The agency dropped testing for international travelers in June.

The Canadian government on Monday is ending its requirements that travelers crossing the U.S.–Canada border have to show proof of vaccination starting Oct. 1.

Jack Phillips

Breaking News Reporter

Follow

Jack Phillips is a breaking news reporter at The Epoch Times based in New York.

Adblock test (Why?)



Health - Latest - Google News
September 26, 2022 at 10:36PM
https://ift.tt/3fSUPkZ

CDC Issues Overhaul to Mask Mandate in Hospitals and Nursing Homes - The Epoch Times
Health - Latest - Google News
https://ift.tt/iGAC7he

Monday, September 26, 2022

Frozen embryos tied to higher risk of pregnancy complications related to high blood pressure, study suggests - CNN

CNN  — 

Pregnancies from in vitro fertilization using frozen embryos appear to be linked to an increased risk of complications related to high blood pressure, or hypertensive disorders, compared with when fresh embryos are used or when a pregnancy is conceived naturally.

That’s according to a study published Monday in the American Heart Association journal Hypertension, which included data on more than 4.5 million pregnancies, spanning almost three decades, across three European nations: Denmark, Norway and Sweden.

The risk of pregnancy complications related to high blood pressure was higher after the transfer of frozen embryos compared with naturally conceived pregnancies, and the risk following fresh embryo transfers was similar to that of naturally conceived pregnancies, the data shows.

More research is needed to determine whether similar findings would emerge in the United States.

The researchers – from the Norwegian University of Science and Technology and other institutions in Europe – analyzed medical birth registries from Denmark that were dated between 1994 and 2014, from Norway dated 1984 to 2015, and from Sweden dated 1985 to 2015. The registries included about 4.4 million pregnancies naturally conceived, 78,300 pregnancies that used fresh embryo transfer and 18,037 pregnancies from frozen embryo transfer.

The researchers compared odds of hypertensive disorders during pregnancy across the groups and found that the unadjusted risk of such disorders was 7.4% after frozen embryo transfer, 5.9% after fresh embryo transfer and 4.3% after natural conception. The data also showed that pregnancies from frozen and fresh embryo transfer were more frequently preterm – 6.6% of the frozen and 8.1% of the fresh, respectively – compared with naturally conceived pregnancies, at 5%.

“Frozen embryo transfers are now increasingly common all over the world, and in the last few years, some doctors have begun skipping fresh embryo transfer to routinely freeze all embryos in their clinical practice, the so-called ‘freeze-all’ approach,” lead study author Dr. Sindre H. Petersen, a Ph.D. fellow at the Norwegian University of Science and Technology in Trondheim, Norway, said in a news release Monday.

“In summary, although most IVF pregnancies are healthy and uncomplicated,” he said, “this analysis found that the risk of high blood pressure in pregnancy was substantially higher after frozen embryo transfer compared to pregnancies from fresh embryo transfer or natural conception.”

Petersen added, “Our results highlight that careful consideration of all benefits and potential risks is needed before freezing all embryos as a routine in clinical practice.”

The findings are “in agreement with earlier population-level studies” showing a higher risk of hypertensive disorders during pregnancy after frozen embryo transfer, the researchers wrote in their study.

Last year, a large study out of France presented at the online annual meeting of the European Society of Human Reproduction and Embryology also found a higher risk of pre-eclampsia and hypertension in pregnancies derived from frozen-thawed embryos – and the risk was found to be greater when the uterus was prepared for implantation with hormone replacement therapies.

“The association between frozen embryo cycles and hypertensive disease in pregnancy has been known for a while, and there is still currently an active debate around the pros and cons of ‘Freeze all for all?’ amongst fertility doctors,” Dr. Ying Cheong, professor of reproductive medicine at the University of Southampton, said in a statement distributed by the UK-based Science Media Centre in July. She was not involved in either study.

“There are two important points to take home here, firstly, whilst frozen embryo transfer technology has transformed reproductive medicine, FET must only be performed where clinically appropriate and secondly, clinicians and scientists need to start joining the dots between what happens at early development and later at birth and beyond, a research area, in my opinion, that is still poorly supported and studied,” Cheong said.

The new study did not evaluate what could be driving this association between frozen embryo transfers and high blood pressure risks, but some IVF doctors question whether it is really fresh vs. frozen.

“There is one thing that is not clear: is it from the actual procedure of freezing the embryo or is it from the protocol used? Most IVF doctors believe from recent studies and evidence that it’s actually the medication protocol, not the IVF procedure,” Dr. Aimee Eyvazzadeh, a San Francisco-based reproductive endocrinologist, who was not involved in the new study, wrote in an email to CNN on Monday.

Get CNN Health's weekly newsletter

Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team.

    “There are different ways to prepare a uterus for transfer,” she said. One protocol involves a corpus luteum cyst, a fluid-filled mass that forms in the ovaries and plays an important role during pregnancy, as the corpus luteum produces the hormone progesterone that is needed during pregnancy. Another protocol relies on medications to mimic ovulation.

    “Studies show that it’s the lack of corpus luteum that increases the risk and this is potentially why a frozen transfer may have a higher risk of pre-eclampsia,” Eyvazzadeh wrote.

    Overall, the new study is “very important” for “anyone taking care of pregnant people after IVF,” she wrote. “Everyone taking care of pregnant people after IVF should pay extremely close attention to this study. More and more studies are showing what IVF doctors already know and that is that IVF after frozen embryo transfer can increase risk of pre-eclampsia.”

    Adblock test (Why?)



    Health - Latest - Google News
    September 27, 2022 at 05:00AM
    https://ift.tt/OnHGhg1

    Frozen embryos tied to higher risk of pregnancy complications related to high blood pressure, study suggests - CNN
    Health - Latest - Google News
    https://ift.tt/iGAC7he

    Viruses May Be “Watching” You – Lying in Wait Before Multiplying and Killing - SciTechDaily

    Illustration of Bacteriophages

    Phages can sense bacterial DNA damage, which triggers them to replicate and jump ship.

    Viruses may be ‘watching’ you – some microbes lie in wait until their hosts unintentionally give them the signal to start multiplying and kill them.

    Especially after more than two years of the COVID-19 pandemic, many people picture a virus as a nasty spiked ball – essentially a mindless killer that gets into a cell and hijacks its machinery to create a gazillion copies of itself before bursting out. For many viruses, including the coronavirus that causes COVID-19, the “mindless killer” moniker is essentially true.

    However, there’s more to virus biology than meets the eye.

    A suitable illustration is HIV, the virus that causes AIDS. HIV is a retrovirus that does not immediately go on a killing spree when it enters a cell. Instead, it integrates itself into your chromosomes and chills, waiting for the proper opportunity to command the cell to make copies of it and burst out to infect other immune cells and eventually cause AIDS.

    Bacteriophages, or simply phages, are naturally occurring viruses that attack and kill bacteria. They cannot infect human cells. Phages are extremely diverse and exist everywhere in the environment, including in our bodies. In fact, humans contain more phages than human cells.

    A phage has three main parts: a head, a sheath, and a tail. The phage uses its tail to attach to a bacterial cell. They use the bacteria to replicate themselves. After finding a “matching” bacterial cell, the phage injects its genetic material, hijacking the system normally used for bacterial reproduction. Instead the system will make thousands more phages, which ultimately burst the bacterial cell, releasing it into the environment.

    Exactly what moment HIV is waiting for is not clear, as it’s still an area of active study. However, research on other viruses has long indicated that these pathogens can be quite “thoughtful” about killing. Of course, viruses cannot think the way you and I do. But, as it turns out, evolution has bestowed them with some pretty elaborate decision-making mechanisms. For example, some viruses will choose to leave the cell they have been residing in if they detect DNA damage. Not even viruses, it appears, like to stay on a sinking ship.

    For over two decades, my laboratory has been studying the molecular biology of bacteriophages, or phages for short, the viruses that infect bacteria. Recently, my colleagues and I demonstrated that phages can listen for key cellular signals to help them in their decision-making. Even worse, they can use the cell’s own “ears” to do the listening for them.

    Escaping DNA damage

    If the enemy of your enemy is your friend, phages are certainly your friends. Phages control bacterial populations in nature, and clinicians are increasingly using them to treat bacterial infections that do not respond to antibiotics.

    The best-studied phage, lambda, works a bit like HIV. Upon entering the bacterial cell, lambda decides whether to replicate and kill the cell outright, like most viruses do, or to integrate itself into the cell’s chromosome, as HIV does. If the latter, lambda harmlessly replicates with its host each time the bacteria divides.


    This video shows a lambda phage infecting E. coli.

    However, like HIV, lambda is not just sitting idle. It uses a special protein called CI like a stethoscope to listen for signs of DNA damage within the bacterial cell. If the bacterium’s DNA gets compromised, that’s bad news for the lambda phage nested within it. Damaged DNA leads straight to evolution’s landfill because it’s useless for the phage that needs it to reproduce. So lambda turns on its replication genes, makes copies of itself, and bursts out of the cell to look for other undamaged cells to infect.

    Tapping the cell’s communication system

    Instead of gathering intel with their own proteins, some phages tap the infected cell’s very own DNA damage sensor: LexA.

    Proteins like CI and LexA are transcription factors that turn genes on and off by binding to specific genetic patterns within the DNA instruction book that is the chromosome. Some phages like Coliphage 186 have figured out that they don’t need their own viral CI protein if they have a short DNA sequence in their chromosomes that bacterial LexA can bind to. Upon detecting DNA damage, LexA will activate the phage’s replicate-and-kill genes, essentially double-crossing the cell into committing suicide while allowing the phage to escape.

    Researchers first reported CI’s role in phage decision-making in the 1980s and Coliphage 186’s counterintelligence trick in the late 1990s. Since then, there have been a few other reports of phages tapping bacterial communication systems. One example is phage phi29, which exploits its host’s transcription factor to detect when the bacterium is getting ready to generate a spore, or a kind of bacterial egg capable of surviving extreme environments. Phi29 instructs the cell to package its DNA into the spore, killing the budding bacteria once the spore germinates.


    Transcription factors turn genes on and off.

    In recently published research, my colleagues and I show that several groups of phages have independently evolved the ability to tap into yet another bacterial communication system: the CtrA protein. CtrA integrates multiple internal and external signals to set in motion different developmental processes in bacteria. Key among these is the production of bacterial appendages called flagella and pili. As it turns out, these phages attach themselves to the pili and flagella of bacteria in order to infect them.

    Our leading hypothesis is that phages use CtrA to guesstimate when there will be enough bacteria nearby sporting pili and flagella that they can readily infect. A pretty smart trick for a “mindless killer.”

    These aren’tt the only phages that make elaborate decisions – all without the benefit of even having a brain. Some phages that infect Bacillus bacteria produce a small molecule each time they infect a cell. The phages can sense this molecule and use it to count the number of phage infections taking place around them. Like alien invaders, this count helps decide when they should switch on their replicate-and-kill genes, killing only when hosts are relatively abundant. This way, the phages make sure that they never run out of hosts to infect and guarantee their own long-term survival.

    Countering viral counterintelligence

    A good question is why you should care about the counterintelligence ops run by bacterial viruses. While bacteria are very different from people, the viruses that infect them are not that different from the viruses that infect humans. Pretty much every single trick played by phages has later been shown to be used by viruses that infect humans. If a phage can tap bacterial communication lines, why wouldn’t a human virus tap yours?

    So far, scientists don’t know what human viruses could be listening for if they hijack these lines, but there are plenty of conceivable options. I believe that, like phages, human viruses could potentially be able to count their numbers to strategize, detect cell growth and tissue formation, and even monitor immune responses. For now, these possibilities are only speculation, but scientific investigation is underway to investigate.

    Having viruses listening to your cells’ private conversations is not the rosiest of pictures, but it’s not without a silver lining. As intelligence agencies all around the world know quite well, counterintelligence only works when it’s covert. Once detected, the system can very easily be exploited to feed misinformation to your enemy. Similarly, I believe that future antiviral therapies may be able to combine conventional artillery, like antivirals that prevent viral replication, with information warfare trickery, such as making the virus believe the cell it is in belongs to a different tissue.

    But, hush, don’t tell anybody. Viruses could be listening!

    Written by Ivan Erill, Associate Professor of Biological Sciences, University of Maryland, Baltimore County.

    This article was first published in The Conversation.The Conversation

    Adblock test (Why?)



    Health - Latest - Google News
    September 26, 2022 at 04:14PM
    https://ift.tt/uZeXLS1

    Viruses May Be “Watching” You – Lying in Wait Before Multiplying and Killing - SciTechDaily
    Health - Latest - Google News
    https://ift.tt/YWyhAkC

    Sunday, September 25, 2022

    New diabetes study shows two drugs outperforming others - NewsNation Now

    [unable to retrieve full-text content]

    New diabetes study shows two drugs outperforming others  NewsNation NowView Full Coverage on Google News

    Health - Latest - Google News
    September 24, 2022 at 05:24AM
    https://ift.tt/6rAeMXH

    New diabetes study shows two drugs outperforming others - NewsNation Now
    Health - Latest - Google News
    https://ift.tt/YWyhAkC

    Can I Get a Second Flu Shot to Boost My Immunity? - Bloomberg

    [unable to retrieve full-text content]

    1. Can I Get a Second Flu Shot to Boost My Immunity?  Bloomberg
    2. A couple of shots worth taking  The Republic
    3. UCSF doctor on upcoming flu season, COVID-19 boosters  KPIX CBS SF Bay Area
    4. What to know about new COVID-19 booster and flu shots  WHO TV 13 Des Moines News & Weather
    5. View Full Coverage on Google News


    Health - Latest - Google News
    September 25, 2022 at 05:00PM
    https://ift.tt/NSCVvs5

    Can I Get a Second Flu Shot to Boost My Immunity? - Bloomberg
    Health - Latest - Google News
    https://ift.tt/a3J8pCq

    Saturday, September 24, 2022

    UCSF doctor on upcoming flu season, COVID-19 boosters - KPIX CBS SF Bay Area

    Adblock test (Why?)



    Health - Latest - Google News
    September 24, 2022 at 08:23AM
    https://ift.tt/VNKePXZ

    UCSF doctor on upcoming flu season, COVID-19 boosters - KPIX CBS SF Bay Area
    Health - Latest - Google News
    https://ift.tt/a3J8pCq

    Friday, September 23, 2022

    Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old - CNBC

    Following CDC approval for vaccination of children aged 6 months to 5 years, 4 year-old Eleanor Kahn sits with her father Alex, as nurse Jillian Mercer administers the Moderna vaccine for the coronavirus disease (COVID-19) at Rady Children’s Hospital in San Diego, California, U.S., June 21, 2022.
    Mike Blake | Reuters

    Moderna has asked the Food and Drug Administration to authorize its omicron booster shots for children, the company announced on Friday.

    Moderna filed two separate FDA authorization requests, one for adolescents ages 12 to 17 and another for kids ages 6 to 11. The Boston biotech company said it will also ask the FDA to clear the shots for the youngest children, 6 months through 5-years-old, later this year.

    The Centers for Disease Control and Prevention, in a document published Tuesday, said it expects children to become eligible for the omicron boosters by mid-October pending authorization by the FDA. The CDC's vaccine advisory committee has meetings scheduled for October 19 and 20.

    Pfizer told the CDC advisory committee earlier this month that it expects to ask the FDA to authorize omicron boosters for children ages 5 to 11 in early October.

    U.S. health regulators cleared Moderna's omicron boosters for adults earlier this month. Pfizer's boosters were authorized for people ages 12 and older.

    The new shots target the omicron BA.5 subvariant as well as the original strain of Covid that first emerged in China in late 2019. The FDA and CDC expect the new boosters to provide superior protection against infection and disease because they target the most common omicron subvariant.

    The old vaccines, which were designed to fight the original Covid strain, are no longer providing meaningful protection against infection and mild illness because the virus has mutated so much. There is also concern that the original shots' effectiveness at preventing hospitalization and severe illness is starting to decline.

    Public health officials are confident in the new omicron BA.5 boosters, though it's unclear just how effective they will be in the real world. The shots were authorized without data from human clinical trials

    Adblock test (Why?)



    Health - Latest - Google News
    September 23, 2022 at 11:06PM
    https://ift.tt/nfdsiEb

    Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old - CNBC
    Health - Latest - Google News
    https://ift.tt/TVUgJHG

    COVID raises risk of long-term brain injury, large U.S. study finds - KSL.com

    Nurses react as they treat a COVID-19 patient in the intensive care unit at Milton Keynes University Hospital in Britain amid the spread of the coronavirus pandemic, Jan. 20, 2021. People who had COVID-19 are at higher risk for a host of brain injuries a year later compared with people who were never infected by the coronavirus. (Toby Melville, Reuters)

    Estimated read time: 2-3 minutes

    CHICAGO — People who had COVID-19 are at higher risk for a host of brain injuries a year later compared with people who were never infected by the coronavirus, a finding that could affect millions of Americans, U.S. researchers reported on Thursday.

    The yearlong study, published in Nature Medicine, assessed brain health across 44 different disorders using medical records without patient identifiers from millions of U.S. veterans.

    Brain and other neurological disorders occurred in 7% more of those who had been infected with COVID compared with a similar group of veterans who had never been infected. That translates into roughly 6.6 million Americans who had brain impairments linked with their COVID infections, the team said.

    "The results show the devastating long-term effects of COVID-19," senior author Dr. Ziyad Al-Aly of Washington University School of Medicine said in a statement.

    Al-Aly and colleagues at Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System studied medical records from 154,000 U.S. veterans who had tested positive for COVID from March 1, 2020, to Jan. 15, 2021.

    They compared these with records from 5.6 million patients who did not have COVID during the same time frame, and another group of 5.8 million people from the period just before the coronavirus arrived in the United States.

    Al-Aly said prior studies looked at a narrower group of disorders, and were focused largely on hospitalized patients, whereas his study included both hospitalized and non-hospitalized patients.

    Memory impairments, commonly referred to as brain fog, were the most common symptom. Compared with the control groups, people infected with COVID had a 77% higher risk of developing memory problems.

    People infected with the virus also were 50% more likely to have an ischemic stroke, which is caused by blood clots, compared with the never-infected group.

    Those who had COVID were 80% more likely to have seizures, 43% more likely to have mental health issues, such as anxiety or depression, 35% more likely to have headaches and 42% more likely to suffer movement disorders, such as tremors, compared with the control groups.

    Researchers said governments and health systems must devise plans for a post-COVID world.

    "Given the colossal scale of the pandemic, meeting these challenges requires urgent and coordinated — but, so far, absent — global, national and regional response strategies," Al-Aly said.

    Photos

    Related stories

    Most recent Coronavirus stories

    Julie Steenhuysen

    More stories you may be interested in

    Adblock test (Why?)



    Health - Latest - Google News
    September 23, 2022 at 10:32PM
    https://ift.tt/d58gLPX

    COVID raises risk of long-term brain injury, large U.S. study finds - KSL.com
    Health - Latest - Google News
    https://ift.tt/TVUgJHG

    Featured Post

    Measles is “growing global threat,” CDC tells doctors in alert message - Ars Technica

    Enlarge / A baby with measles. CDC The Centers for Disease Control and Prevention is putting clinicians on alert about the growing r...

    Popular Posts